Keyphrases
Erythropoietin
100%
Sickle Cell Disease
100%
Hydroxyurea
100%
Fetal Hemoglobin
100%
Sickle Cell Anemia
20%
Hemoglobin S
20%
RhEPO
13%
Consecutive Days
13%
Reticulocytes
13%
Erythrocytes
13%
Globin
13%
F Cells
13%
Percent Increase
13%
Vaso-occlusive
13%
Maximal Value
6%
Cellular Level
6%
Red Cells
6%
Prolonged Treatment
6%
Hemoglobin Level
6%
Oral Iron
6%
Escalating Dose
6%
Direct Bilirubin
6%
Bilirubin Level
6%
Potentiating Effect
6%
Dosing Regimen
6%
Laboratory Animals
6%
Thalassemia
6%
Intracellular Polymerization
6%
Iron Supplementation
6%
Hemoglobin F
6%
Filterability
6%
Sparing Effect
6%
Azacytidine
6%
Rheologic
6%
Iron Sulfate
6%
Pharmacology, Toxicology and Pharmaceutical Science
Erythropoietin
100%
Hydroxycarbamide
100%
Sickle Cell Anemia
100%
Hemoglobin F
100%
Recombinant Erythropoietin
13%
Globin
13%
Disease
6%
Bilirubin
6%
Experimental Animal
6%
Azacitidine
6%
Thalassemia
6%
Ferrous Sulfate
6%